Unraveling the role of osteocytes in metabolic dysfunction associated with obesity
揭示骨细胞在肥胖相关代谢功能障碍中的作用
基本信息
- 批准号:10618056
- 负责人:
- 金额:$ 14.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-15 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:3-DimensionalATAC-seqAblationAffectBehaviorBiochemicalCellsChIP-seqChromatinClinicalCuesDataDietDiseaseDoseEatingEnergy MetabolismEpidemicEpigenetic ProcessFoundationsFunctional disorderFutureGlycolysisGoalsHealthHigh Fat DietHormonesHyperglycemiaHyperlipidemiaIn VitroInterventionKnowledgeLinkMediatingMetabolicMetabolic DiseasesMetabolic dysfunctionMetabolismMitochondriaModelingMolecularMonitorMusMusculoskeletalNeurosecretory SystemsNutrientNutritionalObesityOsteocytesOxidative PhosphorylationPathway interactionsPatternPharmacologyPhenotypePhysiologicalPlayPrevalenceRegulationResearchRoleSIRT1 geneSerumShapesSignal TransductionSkeletonTestingTherapeuticThinnessTimeTissuesTransforming Growth Factor betaTransforming Growth Factor beta ReceptorsWeight GainWorkage relatedbonebone cellbone fragilitydiet-induced obesityenergy balanceepigenomeglucose metabolismhistone modificationimprovedin vivoinsightlipid metabolismmetabolic abnormality assessmentmultiple omicsnoveloutcome predictionprogramsresponsesuccesstraittranscriptometranscriptome sequencing
项目摘要
PROJECT ABSTRACT
The prevalence of obesity is on the rise and a better understanding of the drivers of this epidemic is
crucial. As novel insights implicate bone in regulating energy metabolism, it is crucial to understand how
diseases of positive energy balance, like obesity, affect the different functions of bone. While obesity is known
to impact the structural function of bone causing increased fragility, it is unclear how the metabolic function of
bone is compromised in obesity. Filling this gap in our knowledge is critical for developing therapeutics that can
reestablish energy metabolism while maintaining musculoskeletal health in obesity.
In this proposal, we explore the effects of obesity on bone regulated energy metabolism and focus
particularly on osteocytes, that constitute 95% of cells in bone. Our compelling preliminary data puts forth the
premise that TGFβ signaling is a key modulator of osteocyte-intrinsic energy metabolism (cellular). Thus, we
test the hypothesis that obesity impacts osteocytic TGFβ signaling that in turn contributes to deregulated
systemic energy metabolism. Furthermore, our data suggest that osteocytic TGFβ signaling also coordinates
the activities of epigenetic factors to shape the transcriptome of osteocytes. These epigenetic factors have
previously been implicated in obesity; however, their relation to TGFβ signaling and cellular energy metabolism
of osteocytes remains unexplored. Together, these findings motivate my central hypothesis, that osteocytic
TGFβ signaling drives metabolic dysfunction in obesity through an epigenetic mechanism. My aims to test this
hypothesis are to: 1) determine if obesity induces metabolic reprogramming in osteocytes in a TGFβ-
dependent manner, 2) determine if ablation of osteocytic TGFβ rescues metabolic dysfunction in
obesity, and 3) identify the function of TGFβ responsive epigenetic factors in regulating osteocyte
driven energy metabolism during obesity.
Using hyperglycemia and hyperlipidemia (in vitro) and DIO (diet-induced obesity, in vivo) to model
obesity, we will monitor the link between osteocytic TGFβ signaling, cellular- and systemic- energy
metabolism, and study its role in regulating the obesity-induced metabolic dysfunction. For combining ChIP-
Seq, ATAC-Seq, and RNA-Seq approaches, we will generate a network landscape connecting epigenetic
marks, modifiers, chromatin accessibility patterns, and corresponding molecular pathways that are impacted by
obesity in osteocytes. In the future, this landscape of molecular and epigenetic networks will serve as a
blueprint that can be used to interpret osteocyte function in metabolism in response to distinct nutrient cues.
Such a blueprint will be particularly informative in devising or predicting outcomes of pharmacologic
interventions and will lay the foundation for my independent research that dissects the intricacies behind the
crosstalk between bone function and energy metabolism.
Project Abstract
项目摘要
肥胖症的患病率正在上升,需要更好地了解这种流行病的驱动因素
由于新的见解表明骨骼参与调节能量代谢,因此了解其机制至关重要。
正能量平衡疾病,如肥胖,会影响骨骼的不同功能,而肥胖是众所周知的。
影响骨骼的结构功能,导致脆性增加,目前尚不清楚骨骼的代谢功能如何
肥胖导致骨骼受损,填补这一知识空白对于开发可治疗的疗法至关重要。
重建能量代谢,同时保持肥胖患者的肌肉骨骼健康。
在本提案中,我们探讨了肥胖对骨调节能量代谢的影响,并重点关注
特别是骨细胞,它构成了骨骼中 95% 的细胞,我们令人信服的初步数据表明了这一点。
前提是 TGFβ 信号传导是骨细胞内在能量代谢(细胞)的关键调节剂。
检验肥胖影响骨细胞 TGFβ 信号转导进而导致失调的假设
此外,我们的数据表明骨细胞 TGFβ 信号传导也能协调。
表观遗传因子的活动塑造骨细胞的转录组。
之前曾被认为与肥胖有关;然而,它们与 TGFβ 信号传导和细胞能量代谢的关系
骨细胞的作用仍未被探索,这些发现激发了我的中心假设,即骨细胞。
TGFβ 信号传导通过表观遗传机制驱动肥胖的代谢功能障碍。
假设是:1)确定肥胖是否会诱导 TGFβ- 中骨细胞的代谢重编程
依赖的方式,2)确定骨细胞TGFβ的消融是否可以挽救代谢功能障碍
肥胖,3) 确定 TGFβ 反应性表观遗传因子在调节骨细胞中的功能
肥胖期间驱动能量代谢。
使用高血糖和高脂血症(体外)和 DIO(饮食诱导的肥胖,体内)来建模
肥胖,我们将监测骨细胞 TGFβ 信号传导、细胞能量和全身能量之间的联系
代谢,并研究其在调节肥胖引起的代谢功能障碍中的作用。
Seq、ATAC-Seq 和 RNA-Seq 方法,我们将生成连接表观遗传的网络景观
标记、修饰符、染色质可及性模式以及受其影响的相应分子途径
未来,这种分子和表观遗传网络的景观将成为骨细胞的肥胖症。
可用于解释骨细胞在代谢中响应不同营养线索的功能的蓝图。
这样的蓝图对于设计或预测药理学结果将特别提供信息。
干预措施,并将为我的独立研究奠定基础,剖析背后的复杂性
骨功能和能量代谢之间的串扰。
项目摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neha Dole其他文献
Neha Dole的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neha Dole', 18)}}的其他基金
Unraveling the role of osteocytes in metabolic dysfunction associated with obesity
揭示骨细胞在肥胖相关代谢功能障碍中的作用
- 批准号:
10670979 - 财政年份:2021
- 资助金额:
$ 14.09万 - 项目类别:
Unraveling the role of osteocytes in metabolic dysfunction associated with obesity
揭示骨细胞在肥胖相关代谢功能障碍中的作用
- 批准号:
10283907 - 财政年份:2021
- 资助金额:
$ 14.09万 - 项目类别:
相似国自然基金
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于ATAC-seq技术研究交叉反应物质197调控TFEB介导的自噬抑制子宫内膜异位症侵袭的分子机制
- 批准号:82001520
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
单细胞RNA和ATAC测序解析肌肉干细胞激活和增殖中的异质性研究
- 批准号:31900570
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
人类胎盘合体滋养层形成分子机制及其与子痫前期发生关联的研究
- 批准号:31900602
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Defining and perturbing gene regulatory dynamics in the developing human brain
定义和扰乱人类大脑发育中的基因调控动态
- 批准号:
10658683 - 财政年份:2023
- 资助金额:
$ 14.09万 - 项目类别:
Molecular ontology of drug tolerant persisters in HER2 positive breast cancer - Resubmission - 1
HER2 阳性乳腺癌耐药者的分子本体论 - 重新提交 - 1
- 批准号:
10391866 - 财政年份:2022
- 资助金额:
$ 14.09万 - 项目类别:
Transcriptional and epigenetic regulation of thermogenic adipocyte program
产热脂肪细胞程序的转录和表观遗传调控
- 批准号:
10604352 - 财政年份:2022
- 资助金额:
$ 14.09万 - 项目类别:
Epigenetic regulators of subtype plasticity in bladder cancer
膀胱癌亚型可塑性的表观遗传调节因子
- 批准号:
10579267 - 财政年份:2021
- 资助金额:
$ 14.09万 - 项目类别:
Unraveling the role of osteocytes in metabolic dysfunction associated with obesity
揭示骨细胞在肥胖相关代谢功能障碍中的作用
- 批准号:
10670979 - 财政年份:2021
- 资助金额:
$ 14.09万 - 项目类别: